Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	635.78B +20.0%
Revenue (ttm)	847.45B +4.2%
Net Income	28.84B +11.8%
EPS	2,360.00 +11.7%
Shares Out	12.20M
PE Ratio	22.08
Forward PE	n/a
Dividend	880.00 (1.75%)
Ex-Dividend Date	Apr 2, 2026

Volume	27,534
Average Volume	54,504
Open	51,500
Previous Close	50,300
Day's Range	50,600 - 52,600
52-Week Range	36,200 - 76,700
Beta	0.96
RSI	35.20
Earnings Date	May 14, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.